Baxdela
NDC 70842-102, delafloxacin meglumine, injection, powder, lyophilized, for solution, from Melinta Therapeutics, LLC.
- Product NDC
- 70842-102
- Status
- Listed
- Labeler
- Melinta Therapeutics, LLC
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA208611
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70842-102 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DELAFLOXACIN MEGLUMINE300 mg/10.5mL
Pharmacologic classes
Fluoroquinolone Antibacterial [EPC]; Fluoroquinolones [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70842-102-03 | 70842010203 | 10 VIAL, GLASS in 1 CARTON (70842-102-03) / 10.5 mL in 1 VIAL, GLASS (70842-102-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/fb77637a-88d9-4aea-958f-e270030ce30dMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=70842-102
Use it
Look up 70842-102 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70842-102 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70842-102. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.